Ovid Therapeutics Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Dec 2014 | — | — | $4.8M |
| Dec 2015 | — | — | $69.9M |
| Mar 2016 | — | — | $66.0M |
| Jun 2016 | — | — | $62.5M |
| Sep 2016 | — | — | $57.8M |
| Dec 2016 | $3.7M | $53.0M | $51.9M |
| Mar 2017 | $4.9M | $47.2M | $44.2M |
| Jun 2017 | $7.1M | $108.0M | $106.1M |
| Sep 2017 | $4.6M | $97.6M | $96.0M |
| Dec 2017 | $6.0M | $89.5M | $87.1M |
| Mar 2018 | $6.6M | $78.7M | $29.2M |
| Jun 2018 | $7.5M | $68.6M | $22.5M |
| Sep 2018 | $10.4M | $60.4M | $30.5M |
| Dec 2018 | $8.8M | $47.6M | $36.5M |
| Mar 2019 | $9.4M | $66.7M | $54.6M |
| Jun 2019 | $9.5M | $54.9M | $47.4M |
| Sep 2019 | $10.6M | $40.7M | $37.9M |
| Dec 2019 | $10.8M | $80.8M | $41.9M |
| Mar 2020 | $10.3M | $61.7M | $27.3M |
| Jun 2020 | $14.9M | $45.4M | $41.3M |
| Sep 2020 | $28.0M | $91.6M | $86.9M |
| Dec 2020 | $32.3M | $75.9M | $72.0M |
| Mar 2021 | $16.3M | $237.5M | $233.1M |
| Jun 2021 | $11.3M | $218.0M | $212.2M |
| Sep 2021 | $10.1M | $207.1M | $201.8M |
| Dec 2021 | $14.8M | $194.5M | $187.8M |
| Mar 2022 | $26.1M | $191.1M | $166.7M |
| Jun 2022 | $25.2M | $177.3M | $72.8M |
| Sep 2022 | $23.0M | $165.0M | $58.3M |
| Dec 2022 | $23.0M | $155.3M | $44.9M |
| Mar 2023 | $22.4M | $143.4M | $63.1M |
| Jun 2023 | $25.5M | $136.2M | $71.6M |
| Sep 2023 | $23.7M | $125.0M | $57.4M |
| Dec 2023 | $56.2M | $144.0M | $27.0M |
| Mar 2024 | $53.3M | $131.6M | $30.8M |
| Jun 2024 | $29.2M | $118.1M | $29.7M |
| Sep 2024 | $26.4M | $102.7M | $15.0M |
| Dec 2024 | $23.9M | $92.2M | $26.3M |
| Mar 2025 | $22.4M | $81.7M | $21.1M |
| Jun 2025 | $21.6M | $77.4M | $28.4M |
| Sep 2025 | $19.2M | $63.8M | $20.6M |
| Dec 2025 | $20.3M | $150.9M | $13.2M |
| Mar 2026 | $27.4M | $225.6M | $94.1M |
| Jun 2026 | $22.1M | $232.0M | $11.3M |